Affirm Stock Is Still Not Worth Anywhere Near Its Present Market Value

Stocks to sell

Affirm Holdings (NASDAQ:AFRM), the buy-now, pay-later online financial technology lender that went public in January 2021, is still losing money. That said, I believe AFRM stock will keep dropping as long as Affirm keeps losing money. And this is mainly due to its huge loan losses.

Source: Piotr Swat / Shutterstock.com

The IPO price was $49 on Jan. 13, but the first trade was well above that at $97.75. After that AFRM stock peaked at a close of $139.99 on Feb. 11 when its fiscal Q2 2021 (to Dec. 31) earnings were released. But since then, it has retreated to $69.39 as of April 5.

Therefore, although the stock is still up $20.39 over its $49 IPO price, or +41.6%, it is still down 29% from the peak. Moreover, in the past month to April 5, Affirm stock has dropped over 21%.

In other words, the market is not buying whatever Affirm is trying to sell as a public company. That said, let’s look at some of the main reasons why.

Customers First, Losses Second

It’s nice that Affirm does not charge late fees, annual fees and the other typical fees that other credit card lenders get away with. They also seem to tolerate non-payers longer than other fintech lenders who aren’t so stuck up about their lending philosophy. This is the crux of their “honest” marketing strategy to Millennials.

Nonetheless, the only downside is that Affirm can’t seem to make money by not doing this. Moreover, they seem to have attracted terrible borrowers.

For example, on page 19 of the company’s latest 10-Q, its Allowance for Credit Losses increased from $85.9 million to $131 million during the quarter ending Dec. 31. However, the company said its Allowance as a percent of loans held for investment fell from 9% to 7%. This is because the number of loans increased. My point here is that its loan losses are rising, and that even the 7% number is still very high.

Honest Calculations and Transparency at Affirm

However, to the honesty point, the company actually does not calculate the actual loan loss ratio. For example, the balance indicates that loans held for investment rose from $1.034 billion in June to $1.888 billion by December. That is an average of $1.461 billion.

Now we don’t know if the $131 million in quarterly losses can be extended over that period. There is not enough info. But let’s assume there were two quarters of $131 million in loan losses. That implies the loan loss rate is 17.9% (i.e. $262 million / $1.461 billion). Let’s be generous and just use $131 million in losses. That still implies a loan loss rate of 8.9%, not 7% as the company says.

In other words, there is not a lot of transparency here. I complained about this in my previous article on Affirm. What’s more, the company does not even talk about its net interest margin (NIM). I am not sure that they even have a positive NIM. If Affirm is losing between 8.9% and 17.9% of loan amounts, but making just 15% (my estimate) in interest on those loans, there is a razor-thin or possibly negative NIM.

What To Do With AFRM Stock

Bank of America (BofA) recently came out with a Neutral rating on Affirm. The analyst sees limited upside given the company’s multiple. He was comparing the company’s enterprise value (EV) to sales ratio with other fintech companies.

In fact, of the nine analysts that cover AFRM stock, five of these analysts also have a neutral rating. No one is beating the bush saying the stock is a multi-bagger in the making.

The problem with the BofA analyst’s assessment is that the valuation method glosses over Affirm’s ongoing losses. Getting a larger scale through more customers and more loans may not actually solve this profitability problem. In fact, I suspect that somewhere down the road the company is going to have to find a way to charge some fees to raise its profitability.

So, until the stock is much lower — or its business model becomes much more transparent about the path to profitability — most value investors will stay away from AFRM stock.

On the date of publication, Mark R. Hake did not hold a long or short position in any of the securities in this article.

Mark Hake writes about personal finance on mrhake.medium.com and runs the Total Yield Value Guide which you can review here.

Articles You May Like

Dental supply stock surges on RFK’s anti-fluoride stance, activist involvement
Quantum Computing: The Key to Unlocking AI’s Full Potential?
5 More Trump Stocks to Trade
Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbook
Data centers powering artificial intelligence could use more electricity than entire cities